🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the propellants,1 - Difluoroethane \[...
Status
Completed
Location
GSK Investigational Site
Start Date
2025-03-11
Trial ID
NCT06702462
Treatments Being Tested
The goal of this study is to assess and compare the safety and tolerability...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-05-31
Trial ID
NCT06261957
Treatments Being Tested
This study aims to generate additional safety data on the propellant compon...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-15
Trial ID
NCT07645248
The main goal of the study is to assess the effect of the administration of...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-07-29
Trial ID
NCT06506266
Treatments Being Tested
The primary objective of the study is to characterize the PK of single dose...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-06-04
Trial ID
NCT06433908
Treatments Being Tested
This is a study comparing CHF 5993 pMDI HFA-152a with CHF 1535 pMDI HFA-134...
Status
Recruiting
Location
China-Japan Friendship Hospital
Start Date
2026-06-26
Trial ID
NCT07546981
The CLI-05993AB6-03 Study is an interventional study designed to investigat...
Status
Completed
Location
"IPSMCPP-D-R Veleva" EOOD
Start Date
2023-11-27
Trial ID
NCT06264674
Treatments Being Tested
The primary objective of this study was to assess the effect of multiple do...
Status
Completed
Location
BDD Pharma - Bio-Imaging Centre
Start Date
2023-06-26
Trial ID
NCT05875025
The primary objectives of the study are: Part 1: to characterize the potenc...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-08-14
Trial ID
NCT06433921
Treatments Being Tested
This is a Phase IIa, multicentre, single dose, randomised, double blind, co...
Status
Completed
Location
Medicine Evaluation Unit Limited
Start Date
2022-08-03
Trial ID
NCT05472662
Treatments Being Tested